We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Aeva Technologies
AEVA
$766M
| $0 | ﹤0.01% |
2
| – | – |
2021 Q1
2 quarters
|
|
3027
AFC Gamma
AFCG
$69.7M
| – | – |
-292
| Closed | -$4K | – |
|
3028
First Majestic Silver
AG
$7.93B
| – | – |
-115
| Closed | -$2K | – |
|
3029
Aimco
AIV
$244M
| $0 | ﹤0.01% |
1
-85
| -99% | -$585 |
2016 Q4
19 quarters
|
|
3030
Aldeyra Therapeutics
ALDX
$44.5M
| $0 | ﹤0.01% |
+17
| New | +$156 |
2021 Q3
0 quarters
|
|
3031
Octave Specialty Group
OSG
$207M
| $0 | ﹤0.01% |
16
| – | – |
2020 Q1
6 quarters
|
|
3032
Amneal Pharmaceuticals
AMRX
$6.7B
| $0 | ﹤0.01% |
+84
| New | +$423 |
2021 Q3
0 quarters
|
|
3033
Alpha Metallurgical Resources
AMR
$2.15B
| $0 | ﹤0.01% |
3
| – | – |
2019 Q1
10 quarters
|
|
3034
CALL
Amazon
AMZN
$2.75T
| – | – |
-10,000
| Closed | -$1.72M | – |
|
3035
Artisan Partners
APAM
$2.33B
| $0 | ﹤0.01% |
+8
| New | +$404 |
2021 Q3
0 quarters
|
|
3036
Agora
API
$380M
| – | – |
-50
| Closed | -$2K | – |
|
3037
Algonquin Power & Utilities
AQN
$4B
| $0 | ﹤0.01% |
+20
| New | +$308 |
2021 Q3
0 quarters
|
|
3038
Ares Management
ARES
$25.9B
| $0 | ﹤0.01% |
5
| – | – |
2020 Q1
6 quarters
|
|
3039
Assembly Biosciences
ASMB
$419M
| – | – |
-40
| Closed | -$2K | – |
|
3040
Academy Sports + Outdoors
ASO
$3.6B
| $0 | ﹤0.01% |
+6
| New | +$239 |
2021 Q3
0 quarters
|
|
3041
Astec Industries
ASTE
$896M
| – | – |
-68
| Closed | -$4K | – |
|
3042
Alphatec Holdings
ATEC
$1.69B
| – | – |
-61
| Closed | -$1K | – |
|
3043
Aterian
ATER
$10.5M
| – | – |
-121
| Closed | -$21K | – |
|
3044
Atlanticus Holdings
ATLC
$1.42B
| $0 | ﹤0.01% |
+3
| New | +$146 |
2021 Q3
0 quarters
|
|
3045
Astronics
ATRO
$2.65B
| $0 | ﹤0.01% |
+41
| New | +$520 |
2021 Q3
0 quarters
|
|
3046
Aurora
AUR
$10.8B
| $0 | ﹤0.01% |
+20
| New | +$198 |
2021 Q3
0 quarters
|
|
3047
Autolus Therapeutics
AUTL
$458M
| – | – |
-180
| Closed | -$1K | – |
|
|
AVDL
3048
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-128
| Closed | -$1K | – |
|
3049
Avalo Therapeutics
AVTX
$644M
| – | – |
0
| – | – |
2020 Q1
6 quarters
|
|
3050
DELISTED
The AZEK Co
AZEK
| – | – |
-31
| Closed | -$1K | – |
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.